Hautzentrum Wuppertal
- Address
- lock Available on a paid plan
Hautzentrum Wuppertal - Dermatological Research Center
Hautzentrum Wuppertal is a specialized dermatological research facility dedicated to advancing the treatment of skin conditions through rigorous clinical investigation. The center focuses on developing and evaluating innovative therapeutic approaches for common dermatological disorders, with particular emphasis on sun-related skin damage and precancerous lesions.
- Actinic keratosis treatment protocols and efficacy studies
- Topical therapeutic interventions for precancerous skin lesions
- Comparative effectiveness research in dermatology
The research team at Hautzentrum Wuppertal demonstrates expertise in conducting placebo-controlled clinical trials to establish evidence-based treatment standards for actinic keratosis, a prevalent condition caused by chronic sun exposure. Their work contributes to identifying safe and effective pharmacological solutions for patients with mild to moderate skin lesions, helping to prevent progression to more serious conditions.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 1 by active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 2 161 other sites in Germany
Therapeutic Area Benchmark — Germany
Select a therapeutic area to compare against other sites in Germany.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Germany
Market Share
Country: Germany
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Hautzentrum Wuppertal
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Randomized, Double-Blind Study on the Efficacy and Safety of 5% Potassium Hydroxide Solution Versus Placebo in Treating Mild to Moderate Actinic Keratosis | INFECTOPHARM Arzneimittel und Consilium GmbH | Phase III | Recruiting | Mar 2025 | — |
IMP list
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| POTASSIUM HYDROXIDE | 1 | Unknown | 2025-03-19 | 2025-03-19 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.